11/19
08:20 am
advm
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
High
Report
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
11/5
11:17 am
advm
Rating for ADVM
Low
Report
Rating for ADVM
11/5
11:17 am
advm
Rating for ADVM
Low
Report
Rating for ADVM